PMID: 6113352Jun 27, 1981Paper

Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients

Lancet
C D MitchellH H Balfour

Abstract

11 of 24 immunocompromised patients with mucocutaneous herpes simplex virus (HSV) infections were given intravenous acyclovir in a randomised double-blind placebo-controlled study. Patients receiving acyclovir experienced no major adverse effects. The median times to cessation of new lesion formation, lesion crusting, lesion healing, cessation of pain, and termination of viral shedding were shorter in the acyclovir-treated group than in the placebo group. The time-to-event probability curves for the acyclovir and placebo groups were significantly different for cessation of pain (p=0.032) and termination of viral shedding (p=0.004). The median times to termination of viral shedding were also statistically different (p=0.045). Acyclovir seems to be a non-toxic and effective treatment for mucocutaneous HSV infections in immunocompromised patients.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·G B ElionH J Schaeffer
May 1, 1979·Antimicrobial Agents and Chemotherapy·C S CrumpackerM J Levin
Sep 1, 1980·Antimicrobial Agents and Chemotherapy·K K Biron, G B Elion

❮ Previous
Next ❯

Citations

Nov 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S M Devine, J R Wingard
Jun 1, 1984·European Journal of Pediatrics·J Bogusławska-JaworskaB Rodziewicz
Jan 1, 1984·European Journal of Clinical Pharmacology·P D WhitemanJ Posner
Apr 1, 1984·European Journal of Clinical Microbiology·E de Clercq
Jun 15, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sharon EladUNKNOWN Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/Internationa
Sep 1, 1988·Journal of Virological Methods·S E Straus
Apr 1, 1984·Diagnostic Microbiology and Infectious Disease·C L Howell, M J Miller
Jul 1, 1986·Diagnostic Microbiology and Infectious Disease·C D MitchellH H Balfour
Apr 1, 1984·Clinics in Dermatology·M Seidlin, S E Straus
Oct 17, 1981·Lancet·N A PeterslundH Juhl
Oct 17, 1981·Lancet
Oct 17, 1981·Lancet
Nov 7, 1981·Lancet
Jul 17, 1982·Lancet·B BeanH H Balfour
Mar 27, 1982·Lancet·A MindelA P Fiddian
Sep 8, 1984·Lancet·R Finn, M A Smith
Mar 8, 1986·Lancet
Jun 16, 1983·The New England Journal of Medicine·H H BalfourR E Keeney
Mar 8, 1984·The New England Journal of Medicine
Jun 14, 1984·The New England Journal of Medicine·S E StrausT Creagh-Kirk
Jul 1, 1992·Clinical and Experimental Dermatology·J P Vestey, M Norval
Nov 1, 1996·International Journal of Dermatology·G M PalleschiM Caproni
Jul 1, 1984·Pediatric Dermatology·E G Chadwick, S T Shulman
Nov 1, 1987·Pediatric Dermatology·N Y Olson, J C Hall
Aug 1, 1997·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·R A SeymourA Nolan
Sep 1, 1983·Antimicrobial Agents and Chemotherapy·C A SmithF Rapp
Feb 1, 1987·The British Journal of Ophthalmology·M G Falcon
Oct 30, 1982·British Medical Journal·M C Timbury
Sep 29, 2004·Skin Pharmacology and Physiology·M-H Schmid-Wendtner, H C Korting
Mar 1, 1987·Antimicrobial Agents and Chemotherapy·D Gold, L Corey
Apr 1, 1982·Antimicrobial Agents and Chemotherapy·S M HammerM S Hirsch
Mar 1, 1986·The Journal of Laryngology and Otology·F W Stafford, A R Welch
Mar 29, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Kuldeep Rajpoot
Jul 1, 1984·The Journal of Investigative Dermatology·P A SchafferD M Coen
Jul 1, 1984·The Journal of Investigative Dermatology·S Chou
Jan 1, 1983·Annals of the New York Academy of Sciences·S L SpruanceJ R Cardinal
Jan 1, 1983·International Journal of Dermatology·S Chou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.